$INQD: A Precision Agriculture Technology Company Making

New Post Public Reply Private Reply Replies (0) Message Board
SpotlightGrowth1
137
$INQD: A Precision Agriculture Technology Company Making Waves in the Cannabis Industry

View Full Original Article Here: http://spotlightgrowth.com/index.php/2019/01/...-industry/

Indoor Harvest Corp. (“Indoor Harvest” or the “Company”) (OTCQB: INQD) is a precision agriculture technology company that is focused on leveraging its proprietary technology to help legal cannabis companies lower operating costs and improve efficiency; while increasing crop yield, consistency, and quality. The Company has a proprietary aeroponic system in development that enables the production of chemically consistent, contaminate-free cannabis, economically at scale. This is expected to also enable Indoor Harvest to leverage its technology over the longer term to develop a better product for the next generation of personalized cannabis-based medicines and treatments.

Rather than focusing on simply cultivating cannabis and entering an increasingly crowded consumer market, Indoor Harvest plans to take a more scientific and technology-based approach to the cannabis industry by focusing on controlled environment cultivation, serving cultivators both short term cost, quality and consistency issues and long-term product development goals.

In partnership with cultivators, Indoor Harvest believes it can share revenues with cultivators, based on savings the aeroponic cultivation technology delivers. Alternatively, the company believes they can license the technology to cultivators.

The team at Indoor Harvest has a strong background in vertical farming and controlled environment agricultural technology, while the new CEO has strong connections to cannabis genetics and tissue culture. This knowledge and expertise are what sets Indoor Harvest apart from the average cannabis company.

Dan Weadock was appointed as the Chief Executive Officer at Indoor Harvest almost one year ago bringing a wealth of knowledge and relationships to help expand the Company’s vision beyond aeroponics. As a co-founder of Integrated Genetics & BioPharma Research, LLC (IGBR), a private Massachusetts company focused on delivering what they expect to be commercial grade, boutique cannabis clones from tissue culture, to the legal Massachusetts cannabis markets, Mr Weadock brings this new dynamic of plant genetics and biology to the team, with access to top quality cannabis genetics and plant scientists, along with his understanding of the critical role of the interplay between the biology of the plants and the mechanical /controlled environment.

The goal for Indoor Harvest is a more integrated and holistic vision, bringing in new elements of plant science with controlled environment technology through collaboration, partnerships, mergers and acquisitions.

Indoor Harvest Corp. is currently focused on two primary objectives:

Building a demonstration showcase of the Aeroponic technology platform in the Boston area, on its own or in partnerships with others, while at the same time exploring research and development opportunities; and
Entering into partnerships and exploring merger & acquisition opportunities across the cannabis industry, with other synergistic science and tech focused companies.

Boston, Massachusetts Opportunities

Indoor Harvest recently announced that it is moving its operational focus to Boston, Massachusetts. The decision is due to a few major factors listed below:

Massachusetts has legal medical and recreational cannabis markets;
Massachusetts is offering a cannabis research license; and
Massachusetts provides friendlier environment to implement an expanded cannabis research and development operation. Massachusetts has legal medical and recreational cannabis markets.

The Company has signed a non-binding Memorandums of Understanding (MOUs) with Cannabis Community Care and Research Network (“C3RN”) and Integrated Genetics & BioPharma Research (“IGBR” also co-owned by Dan Weadock) all of which are located in the Boston area. Indoor Harvest plans to explore the development to acquire or lease property with these partners to pursue research and development opportunities together.

Conclusion

Indoor Harvest is positioning itself to become a player in niche areas of the high-growth cannabis industry. The Company is able to set itself apart from competitors through its proprietary precision agriculture technology and its new network of relationships in cannabis genetics, tissue culture and R&D. While the cannabis industry may be overly-focused on mass cultivation/production and supplying consumer recreational markets, the real growth story is in the science and technology that will take the industry to the next level: precision agriculture technology, controlled environment agricultural technology, cannabis genetics and tissue culture and bio-agriculture. Indoor Harvest is on the forefront of this movement and will only continue to build on its solid foundation as management executes the growth plan.

Disclaimer:

Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.

All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated twenty thousand dollars cash for the creation and dissemination of this content.

This material does not represent an investment solicitation. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.

The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.

Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: http://spotlightgrowth.com/index.php/disclosures/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading